Inflammatory Bowel Disease (IBD), including Crohn's disease and ulcerative colitis, is a chronic inflammatory condition of the digestive tract. Advances in early diagnosis through biomarkers and imaging are improving treatment outcomes. Precision medicine and biologics are providing targeted therapies, reducing disease flare-ups. The gut microbiome is also playing a crucial role in disease progression and treatment response.
Track 3-1: Advances in IBD Diagnosis
Track 3-2: Biologics and Immunotherapy in IBD
Track 3-3: Precision Medicine for IBD
Track 3-4: Microbiome and IBD
Track 3-5: Surgical Management of IBD
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
